rs7080536

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 1P and 13B. PP3BP4_StrongBP6BS1BS2

The NM_004132.5(HABP2):​c.1601G>A​(p.Gly534Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0339 in 1,613,420 control chromosomes in the GnomAD database, including 1,123 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.023 ( 54 hom., cov: 32)
Exomes 𝑓: 0.035 ( 1069 hom. )

Consequence

HABP2
NM_004132.5 missense

Scores

9
7
1

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4O:2

Conservation

PhyloP100: 9.29

Publications

102 publications found
Variant links:
Genes affected
HABP2 (HGNC:4798): (hyaluronan binding protein 2) This gene encodes a member of the peptidase S1 family of serine proteases. The encoded preproprotein is secreted by hepatocytes and proteolytically processed to generate heavy and light chains that form the mature heterodimer. Further autoproteolysis leads to smaller, inactive peptides. This extracellular protease binds hyaluronic acid and may play a role in the coagulation and fibrinolysis systems. Mutations in this gene are associated with nonmedullary thyroid cancer and susceptibility to venous thromboembolism. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

PP3
Multiple lines of computational evidence support a deleterious effect 7: AlphaMissense, BayesDel_noAF, Eigen, phyloP100way_vertebrate, PROVEAN, REVEL, REVEL [when max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.009163111).
BP6
Variant 10-113588287-G-A is Benign according to our data. Variant chr10-113588287-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 5974.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.023 (3503/152236) while in subpopulation NFE AF = 0.0375 (2549/67994). AF 95% confidence interval is 0.0363. There are 54 homozygotes in GnomAd4. There are 1671 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 3503 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004132.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HABP2
NM_004132.5
MANE Select
c.1601G>Ap.Gly534Glu
missense
Exon 13 of 13NP_004123.1Q14520-1
HABP2
NM_001177660.3
c.1523G>Ap.Gly508Glu
missense
Exon 13 of 13NP_001171131.1Q14520-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HABP2
ENST00000351270.4
TSL:1 MANE Select
c.1601G>Ap.Gly534Glu
missense
Exon 13 of 13ENSP00000277903.4Q14520-1
HABP2
ENST00000883707.1
c.1601G>Ap.Gly534Glu
missense
Exon 14 of 14ENSP00000553766.1
HABP2
ENST00000542051.5
TSL:2
c.1523G>Ap.Gly508Glu
missense
Exon 13 of 13ENSP00000443283.1Q14520-2

Frequencies

GnomAD3 genomes
AF:
0.0230
AC:
3501
AN:
152118
Hom.:
54
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00662
Gnomad AMI
AF:
0.00658
Gnomad AMR
AF:
0.0175
Gnomad ASJ
AF:
0.0115
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00932
Gnomad FIN
AF:
0.0268
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0375
Gnomad OTH
AF:
0.0158
GnomAD2 exomes
AF:
0.0223
AC:
5608
AN:
251244
AF XY:
0.0231
show subpopulations
Gnomad AFR exome
AF:
0.00584
Gnomad AMR exome
AF:
0.00773
Gnomad ASJ exome
AF:
0.0100
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0268
Gnomad NFE exome
AF:
0.0364
Gnomad OTH exome
AF:
0.0242
GnomAD4 exome
AF:
0.0350
AC:
51163
AN:
1461184
Hom.:
1069
Cov.:
30
AF XY:
0.0342
AC XY:
24836
AN XY:
726928
show subpopulations
African (AFR)
AF:
0.00532
AC:
178
AN:
33468
American (AMR)
AF:
0.00772
AC:
345
AN:
44694
Ashkenazi Jewish (ASJ)
AF:
0.0117
AC:
306
AN:
26116
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39694
South Asian (SAS)
AF:
0.00908
AC:
783
AN:
86186
European-Finnish (FIN)
AF:
0.0274
AC:
1462
AN:
53416
Middle Eastern (MID)
AF:
0.00819
AC:
47
AN:
5740
European-Non Finnish (NFE)
AF:
0.0416
AC:
46289
AN:
1111504
Other (OTH)
AF:
0.0290
AC:
1750
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
2446
4892
7338
9784
12230
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1720
3440
5160
6880
8600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0230
AC:
3503
AN:
152236
Hom.:
54
Cov.:
32
AF XY:
0.0224
AC XY:
1671
AN XY:
74438
show subpopulations
African (AFR)
AF:
0.00660
AC:
274
AN:
41542
American (AMR)
AF:
0.0175
AC:
267
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0115
AC:
40
AN:
3464
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5178
South Asian (SAS)
AF:
0.00954
AC:
46
AN:
4824
European-Finnish (FIN)
AF:
0.0268
AC:
285
AN:
10618
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0375
AC:
2549
AN:
67994
Other (OTH)
AF:
0.0156
AC:
33
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
171
342
513
684
855
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0314
Hom.:
386
Bravo
AF:
0.0214
TwinsUK
AF:
0.0458
AC:
170
ALSPAC
AF:
0.0516
AC:
199
ESP6500AA
AF:
0.00658
AC:
29
ESP6500EA
AF:
0.0388
AC:
334
ExAC
AF:
0.0222
AC:
2697
Asia WGS
AF:
0.00289
AC:
10
AN:
3478
EpiCase
AF:
0.0343
EpiControl
AF:
0.0332

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
Factor VII Marburg I Variant Thrombophilia (1)
-
-
1
FACTOR VII-ACTIVATING PROTEASE MARBURG I POLYMORPHISM (1)
-
1
-
Thyroid cancer, nonmedullary, 5 (1)
-
-
-
THYROID CANCER, NONMEDULLARY, 5, SUSCEPTIBILITY TO (1)
-
-
-
Venous thromboembolism, susceptibility to (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.81
BayesDel_addAF
Uncertain
0.076
D
BayesDel_noAF
Pathogenic
0.37
CADD
Uncertain
26
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.60
D
Eigen
Pathogenic
0.76
Eigen_PC
Pathogenic
0.70
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.94
D
MetaRNN
Benign
0.0092
T
MetaSVM
Uncertain
0.39
D
MutationAssessor
Uncertain
2.6
M
PhyloP100
9.3
PrimateAI
Uncertain
0.60
T
PROVEAN
Pathogenic
-6.1
D
REVEL
Pathogenic
0.84
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.32
MPC
0.058
ClinPred
0.023
T
GERP RS
5.9
Varity_R
0.95
gMVP
0.89
Mutation Taster
=93/7
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7080536; hg19: chr10-115348046; COSMIC: COSV63490531; COSMIC: COSV63490531; API